A detailed history of Bank Of Montreal transactions in Vaxart, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 15,125 shares of VXRT stock, worth $8,772. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,125
Previous 15,125 -0.0%
Holding current value
$8,772
Previous $10,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$0.56 - $1.41 $8,470 - $21,326
15,125 New
15,125 $19,000
Q4 2022

Feb 01, 2023

BUY
$0.75 - $2.24 $1,570 - $4,690
2,094 Added 10.63%
21,786 $20,000
Q3 2022

Nov 10, 2022

BUY
$2.09 - $4.5 $2,804 - $6,039
1,342 Added 7.31%
19,692 $44,000
Q2 2022

Aug 11, 2022

BUY
$2.7 - $5.28 $49,545 - $96,888
18,350 New
18,350 $67,000
Q1 2022

May 12, 2022

SELL
$4.29 - $6.64 $64,894 - $100,443
-15,127 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$5.77 - $7.96 $87,282 - $120,410
15,127 New
15,127 $98,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $73.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.